A Synergistic DNA-polydopamine-MnO2 Nanocomplex for Near-Infrared-Light-Powered DNAzyme-Mediated Gene Therapy
DNAzyme is emerging for gene therapy. The administration of the in vivo catalytic activity of
DNAzyme has proven important but challenging for clinical applications. Herein, we report a …
DNAzyme has proven important but challenging for clinical applications. Herein, we report a …
A Synergistic DNA-polydopamine-MnO2 Nanocomplex for Near-Infrared-Light-Powered DNAzyme-Mediated Gene Therapy.
H Zhao, Z Zhang, D Zuo, L Li, F Li, D Yang - Nano Letters, 2021 - europepmc.org
DNAzyme is emerging for gene therapy. The administration of the in vivo catalytic activity of
DNAzyme has proven important but challenging for clinical applications. Herein, we report a …
DNAzyme has proven important but challenging for clinical applications. Herein, we report a …
[引用][C] A Synergistic DNA-polydopamine-MnO2 Nanocomplex for Near-Infrared-Light-Powered DNAzyme-Mediated Gene Therapy
H Zhao, Z Zhang, D Zuo, L Li, F Li, D Yang - Nano Letters, 2021 - ui.adsabs.harvard.edu
A Synergistic DNA-polydopamine-MnO2 Nanocomplex for Near-Infrared-Light-Powered
DNAzyme-Mediated Gene Therapy - NASA/ADS Now on home page ads icon ads Enable …
DNAzyme-Mediated Gene Therapy - NASA/ADS Now on home page ads icon ads Enable …
A Synergistic DNA-polydopamine-MnO2 Nanocomplex for Near-Infrared-Light-Powered DNAzyme-Mediated Gene Therapy
H Zhao, Z Zhang, D Zuo, L Li, F Li, D Yang - Nano letters, 2021 - pubmed.ncbi.nlm.nih.gov
DNAzyme is emerging for gene therapy. The administration of the in vivo catalytic activity of
DNAzyme has proven important but challenging for clinical applications. Herein, we report a …
DNAzyme has proven important but challenging for clinical applications. Herein, we report a …